Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/1991
05/07/1991US5013662 Bacterial methionine n-terminal peptidase
05/07/1991US5013658 Transposon tagging of genes in transformed plants
05/07/1991US5013653 Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
05/07/1991US5013652 DNA sequence for expression of polypeptides
05/07/1991US5013650 Increased fermentation yield of expressed protein
05/07/1991US5013649 Proteins; bone disorders
05/07/1991US5013568 Method for treating fish with alpha-2-macroglobulin
05/07/1991US5013550 Antibiotics called "chloropolysporins B and C", a process for their preparation, and their therapeutic and veterinary use
05/07/1991US5013548 Vaccines against AIDS
05/07/1991US5013542 Applying polypeptide derived from proline rich protein contained in saliva
05/07/1991US5013445 Liquid chromatography, porous gel solid phase, no adjustment of buffer solution pH
05/07/1991CA2029289A1 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them
05/07/1991CA2027601A1 Antitumor antibiotic bu-3983t
05/07/1991CA1284000C Process for recovering glucagon from pancreas glands
05/07/1991CA1283856C Purification of immunoglobulin g
05/04/1991CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/04/1991CA2029268A1 Peptides aiding nerve regeneration
05/04/1991CA2029241A1 Inhibitors of tospovirus
05/04/1991CA2029146A1 Promoter regions of the genes which code for the pilinic subunits fim2, fim3 and fimx of bordetella pertussis and their use for the expression of genes which code for a protein ofinterest
05/03/1991WO1991006857A1 Immunoassay of human thrombomodulin, and reagent and kit therefor
05/03/1991CA2044629A1 Method for the immunological assay of human thrombomodulin, reagent therefor and kit therefor
05/03/1991CA2029216A1 Process of producing modified superoxide dismutase
05/02/1991WO1991005871A1 Bispecific heteroantibodies with dual effector functions
05/02/1991WO1991005869A1 Fungal cell wall material with flocculant properties, method for its production
05/02/1991WO1991005867A1 Erythropoietin isoforms
05/02/1991WO1991005866A1 Novel expression systems utilizing bacteriophage t7 promoters and gene sequences
05/02/1991WO1991005864A1 Production of genetically-engineered vaccines for aids and other retroviral diseases
05/02/1991WO1991005863A1 Recombinant growth factors
05/02/1991WO1991005862A1 cDNA FRAGMENT CODING THE ALPHA INTERFERON RECEPTOR GENE AND PROCESS FOR THE PREPARATION OF A CORRESPONDING PROTEIN
05/02/1991WO1991005858A1 A microperoxidase preparation containing a hemopeptide as an active component
05/02/1991WO1991005855A1 Modified biological material
05/02/1991WO1991005853A1 Growth hormone antagonists
05/02/1991WO1991005803A1 Recombinant human thrombomodulin
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991005571A1 Method for producing bone marrow growth cell factors
05/02/1991WO1991005567A1 Vaccins for protecting against infections by hiv virus, process for producing the same and their use as diagnostic and immunotherapy means
05/02/1991WO1991005566A1 Protease nexin i/dextran sulfate anticoagulant
05/02/1991WO1991004273A3 Novel peptides associated with the cd4 binding region of gp120 and their methods of use
05/02/1991WO1990013306A3 Small polypeptides
05/02/1991EP0425212A2 Cyclic anti-aggregatory peptides
05/02/1991EP0425096A1 Polypeptides useful as blockers of calcium channels
05/02/1991EP0425082A1 Bordetella vaccines
05/02/1991EP0425004A2 Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus
05/02/1991EP0424990A1 The manufacture and expression of large structural genes
05/02/1991EP0424819A1 Reversible modification of biological compounds for detection, separation and purification thereof
05/02/1991EP0424771A1 Plasmids and hosts for the expression of INA protein (ice nucleating protein)
05/02/1991EP0424748A1 Synthetic envelope peptides of HTLV-I
05/02/1991EP0424670A1 ZNS-active hexapeptides with antiamnestic activity
05/02/1991EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship.
05/02/1991EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor
05/02/1991EP0424429A1 New expression vectors
05/02/1991EP0424413A1 Dna segment, plasmid containing this segment, transformed bacteria and transformed plant material
05/02/1991EP0424386A1 Device for site directed neovascularization and method for same
05/02/1991EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
05/02/1991EP0205564B1 Method for the production of erythropoietin
05/02/1991CA2067235A1 Modified biological material
05/02/1991CA2042577A1 Osteogenic devices
05/01/1991WO1991006652A1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
05/01/1991WO1991006651A1 Gene conferring salt tolerance
05/01/1991WO1991006641A1 Enhancement of cell growth by expression of a cloned hemoglobin gene
05/01/1991WO1991006637A1 Subtilisin mutants
05/01/1991WO1991006628A1 Expression of bacterial hemoglobin and enhancement of expression of cloned and native products in streptomyces
05/01/1991WO1991006573A1 Inhibitor of laminin neurite promoting activity
05/01/1991WO1991006543A1 GnRH ANALOGS
05/01/1991WO1991006318A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna
05/01/1991WO1991006308A1 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
05/01/1991CN1051058A Cloning and expression of microbial phytase
05/01/1991CA2072149A1 Enhancement of cell growth by expression of a cloned hemoglobin gene
05/01/1991CA2072115A1 Expression of bacterial hemoglobin and enhancement of expression of cloned and native products in streptomyces
05/01/1991CA2070395A1 Gene conferring salt tolerance
05/01/1991CA2066658A1 Inhibitor of laminin neurite promoting activity
05/01/1991CA2066184A1 Gnrh analogs
05/01/1991CA2044244A1 Antibacterial composition
05/01/1991CA2027317A1 Vaccine composition with non-immunosuppressive t-cell epitope component
05/01/1991CA2002000A1 Echinoderm agglutinin and method of extraction
05/01/1991CA2001978A1 Dentin chondrogenic inductive agent
04/1991
04/30/1991US5011952 Phospholipase A2 inhibitor
04/30/1991US5011915 Centrifuging yeast membrane extract, then diafiltation in guanidine hydrochloride solution, solubilizing with denaturing agent and reducing agent
04/30/1991US5011914 Purified ciliary neurotrophic factor
04/30/1991US5011912 Calcium-dependent affinity for selected peptide terminal sequence
04/30/1991US5011910 Heptapeptides having fluorogenic and quenching groups as substrates for protease; colorimetric analysis, efficiency
04/30/1991US5011825 Treatment of hypertension, diabetes, edema
04/30/1991US5011778 Medicament for blocking inflammatory responses
04/30/1991US5011777 Vectors encoding brain derivable polypeptide factors
04/30/1991US5011772 High yield protein production system
04/30/1991US5011691 Protein from DNA expression, a pair of polypeptide chains; implanting to induce endochondral bone formation in mammals
04/30/1991US5011687 Purified Mullerian inhibiting substance and process for treating human ovarian cancer cells
04/30/1991US5011686 Injectable reagent with affinity for fibrin
04/30/1991US5011685 Baculovirus proteins and viral pesticides containing same
04/30/1991CA2001756A1 New human lymphotoxin n-end deletion mutant
04/30/1991CA1283602C Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
04/29/1991CA2028665A1 Bioavailability of pharmaceutical active compounds with peptide linkages
04/28/1991WO1991006650A1 C1 inhibitor muteins and uses thereof
04/28/1991WO1991006572A1 Diagnosis of glomerulonephritis
04/28/1991WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE
04/28/1991WO1991006561A1 Method for treating hiv and other retroviruses and compounds useful therefor
04/28/1991WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2071871A1 C1 inhibitor muteins and uses thereof
1 ... 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 ... 2916